EyePoint Pharmaceuticals

SEC Filings

Form Description Filing date View
4

Statement of changes in beneficial ownership of securities

View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
8-K

Report of unscheduled material events or corporate event

View HTML
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

View HTML
10-K/A

Amendment to a previously filed 10-K

View HTML
CT ORDER

CT ORDER

View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
8-K

Report of unscheduled material events or corporate event

View HTML
EyePoint Pharmaceuticals